Nov 17 Watch 6:45 As Trump claims fraud, officials say this election was ‘the most secure’ By William Brangham, Courtney Norris President Trump and his allies continue to sow doubt over the American electoral process, questioning the intentions of election administrators and poll workers and falsely claiming rampant voter fraud. How do these essential workers, who represent both parties, feel about… Continue watching
Nov 17 Watch 6:33 A year after virus appeared, Wuhan tells China’s pandemic story By Patrick Fok The first known case of infection from the novel coronavirus was recorded one year ago, in China’s Hubei province. The city of Wuhan was infamous the world over as the original virus epicenter, seeing more than half of China’s reported… Continue watching
Nov 17 2 COVID-19 vaccine candidates may protect against the virus. Now what? By Laura Santhanam Even if vaccines are approved and enough doses are made, widespread immunity also depends on how many people are willing to roll up their sleeves. Continue reading
Nov 17 States plead for more federal help as virus outbreak worsens By Geoff Mulvihill, Rachel La Corte, Associated Press With more shutdowns looming and a vaccine months away from wide distribution, governors across the U.S. are pleading for more help from Washington ahead of what is shaping up to be a bleak winter. Continue reading
Nov 16 Watch 3:32 Moderna’s vaccine trials bring hope as more states resume pandemic restrictions By William Brangham, Patty Morales The U.S. is facing both despair and hope regarding the COVID-19 pandemic. With total infections over 11 million nationwide, the virus is continuing to wreak havoc, leading to rising hospitalizations and deaths -- and reimposed restrictions. But at the same… Continue watching
Nov 16 Watch 9:06 What we know about Moderna’s COVID-19 vaccine candidate — and what we don’t The drug company Moderna has released encouraging data from research on its COVID-19 vaccine candidate. The research has not yet been published in a peer-reviewed medical journal, but it is nonetheless raising hopes. Noubar Afeyan is a co-founder and chairman… Continue watching
Nov 16 Watch 6:47 Head of NIH urges Americans to take precautions while awaiting vaccine Early results from Pfizer and Moderna vaccine candidates are very encouraging. But even if a successful vaccine is developed, challenges around production and distribution remain -- not to mention public trust and willingness to receive it. Dr. Francis Collins, director… Continue watching
Nov 16 Early data from Moderna suggests successful 2nd COVID vaccine candidate By Associated Press Moderna said Monday its COVID-19 vaccine is proving to be highly effective in a major trial. Continue reading
Nov 16 Two middle schoolers, their mom and their teacher on what it’s like to learn in the pandemic By Amna Nawaz, Gretchen Frazee, Vika Aronson, Erica R. Hendry, Emily Carpeaux Months into the COVID-19 pandemic, schools are using all kinds of models -- virtual, in-person or some hybrid inbetween -- to try to keep kids on track and engaged. Parents and teachers say sometimes it feels like none of them… Continue reading
Nov 15 Biden advisers to meet vaccine firms as Trump stalls handoff By Will Weissert, Associated Press Joe Biden’s scientific advisers will meet with vaccine makers in coming days as the presidential transition remains stalled because of President Donald Trump’s refusal to acknowledge that he lost the election. That delayed handoff is especially problematic during a public… Continue reading